Related Experiment Video
Updated: Jun 17, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase
Stefania Catalano1, Rocco Malivindi, Cinzia Giordano
1Department of Pharmaco-Biology, University of Calabria, 87030 Arcavacata di Rende (CS), Italy
Abstract:
The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that regulates bile acid homeostasis. It is expressed in the liver and the gastrointestinal tract, but also in several non-enterohepatic tissues including testis. Recently, FXR was identified as a negative modulator of the androgen-estrogen-converting aromatase enzyme in human breast cancer cells. In the present study we detected the expression of FXR in Leydig normal and tumor cell lines and in rat testes tissue. We found, in rat Leydig tumor cells, R2C, that FXR activation by the primary bile acid chenodeoxycholic acid (CDCA) or a synthetic agonist GW4064, through a SHP-independent mechanism, down-regulates aromatase expression in terms of mRNA, protein levels, and its enzymatic activity. Transient transfection experiments, using vector containing rat aromatase promoter PII, evidenced that CDCA reduces basal aromatase promoter activity. Mutagenesis studies, electrophoretic mobility shift, and chromatin immunoprecipitation analysis reveal that FXR is able to compete with steroidogenic factor 1 in binding to a common sequence present in the aromatase promoter region interfering negatively with its activity. Finally, the FXR-mediated anti-proliferative effects exerted by CDCA on tumor Leydig cells are at least in part due to an inhibition of estrogen-dependent cell growth. In conclusion our findings identify for the first time the activators of FXR as negative modulators of the aromatase enzyme in Leydig tumor cell lines.
Insights
Farnesoid X receptor (FXR) activation inhibits aromatase in rat Leydig tumor cells. This FXR-mediated effect, independent of SHP, reduces estrogen production and cell growth, identifying FXR activators as potential therapeutic agents.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Farnesoid X receptor (FXR) regulates bile acid homeostasis and is found in non-enterohepatic tissues like the testis.
- FXR has been identified as a negative modulator of aromatase in human breast cancer cells.
- Aromatase is crucial for estrogen synthesis, and its dysregulation is implicated in various cancers.
Purpose of the Study:
- To investigate the role of FXR in regulating aromatase expression and activity in Leydig cells.
- To determine the mechanism by which FXR modulates aromatase in Leydig tumor cells.
- To explore the potential anti-proliferative effects of FXR activation in Leydig tumor cells.
Main Methods:
- Detection of FXR expression in rat Leydig normal and tumor cell lines and testicular tissue.
- Activation of FXR using chenodeoxycholic acid (CDCA) or GW4064 in R2C Leydig tumor cells.
- Analysis of aromatase mRNA, protein levels, and enzymatic activity.
- Reporter gene assays, mutagenesis, electrophoretic mobility shift assays (EMSA), and chromatin immunoprecipitation (ChIP) to elucidate the mechanism of FXR action.
- Assessment of cell proliferation and estrogen-dependent growth.
Main Results:
- FXR activation by CDCA or GW4064 down-regulates aromatase expression (mRNA, protein, activity) in rat Leydig tumor cells via a SHP-independent pathway.
- CDCA reduces basal aromatase promoter activity.
- FXR competes with steroidogenic factor 1 for binding to the aromatase promoter, inhibiting its activity.
- FXR activation exhibits anti-proliferative effects on Leydig tumor cells, partly by inhibiting estrogen-dependent growth.
Conclusions:
- FXR activators are identified as negative modulators of the aromatase enzyme in Leydig tumor cell lines.
- FXR plays a significant role in regulating estrogen synthesis in testicular Leydig cells.
- FXR activation may represent a novel therapeutic strategy for estrogen-dependent testicular tumors.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Intracellular Hormone Receptors
Regulation of Nuclear Protein Sorting
Internal Receptors
Signal Transduction: Overview
Typically, signal transduction involves three...
